Johnson & Johnson offers up to $5.5bn to settle baby powder lawsuits
The proposed settlement aims to close a years-long legal battle over claims its talcs products cause cancer.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"the allegations are 'meritless' and that J&J was willing to settle in order to finally resolve the matter."
— Erik Haas , Executive
"the company is confident that it would have 'ultimately prevailed with further litigation' just as it has in the majority of cases heard in court to date."
— Erik Haas , Executive
"the proposed resolution 'allows the company to put this matter behind it' and enable J&J to 'remain focused on its mission to develop medicines and devices that save lives.'"
— Erik Haas , Executive
Locations
All Coverage
The proposed settlement aims to close a years-long legal battle over claims its talcs products cause cancer.
Similar Stories
Related coverage based on topic and tags
Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion - Reuters
Merck licenses SciBrunch cancer drug in deal worth up to $2.13 billion Reuters
September 28, 2026 at 04:14 PMUS jury says Apple owes record $5.7 billion in haptic technology patent case - Reuters
US jury says Apple owes record $5.7 billion in haptic technology patent case Reuters
September 26, 2026 at 02:33 PMAstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up - Reuters
AstraZeneca to invest $2 billion in Summit Therapeutics for cancer drug tie-up Reuters
September 28, 2026 at 10:15 PMApple ordered to pay $5.7bn after losing vibration tech patent suit
Audio firm Taction Technology claimed Apple infringed its patents for tech used to power device vibrations.
September 28, 2026 at 11:16 AMLawyer Tony Buzbee must face $25 million defamation lawsuit, judge says - Reuters
Lawyer Tony Buzbee must face $25 million defamation lawsuit, judge says Reuters
October 1, 2026 at 09:34 PMBayer to invest $2.2 billion in new US pharma site - Reuters
Bayer to invest $2.2 billion in new US pharma site Reuters
October 2, 2026 at 07:19 PM